If Minelab sales continue to fall it will need to make another acquisition but alas has its newly found debt position to negotiate through first. Risks are huge and thus we have a value play or a value trap. I have read a couple of reports and they don't expect EPS to grow 20% over next three years if Minelab sales don't get a move on where bottom end of valuation range is $5.70. Those that are selling have solid and valid reasons - I am holding and accumulated more as I think forward p/e of 10x is a little on the low side and think dividend yield at 4.5% is fairly safe for now despite Minelab and debt issues.
- Forums
- ASX - By Stock
- Ann: FY22 half-year investor presentation
CDA
codan limited
Add to My Watchlist
0.80%
!
$20.08

If Minelab sales continue to fall it will need to make another...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$20.08 |
Change
0.160(0.80%) |
Mkt cap ! $3.645B |
Open | High | Low | Value | Volume |
$20.18 | $20.34 | $20.00 | $4.960M | 246.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2179 | $20.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.20 | 5530 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 20.000 |
1 | 150 | 19.900 |
1 | 50 | 19.800 |
1 | 51 | 19.510 |
1 | 300 | 19.500 |
Price($) | Vol. | No. |
---|---|---|
20.200 | 2000 | 1 |
20.250 | 5000 | 1 |
20.390 | 490 | 1 |
20.400 | 335 | 2 |
20.480 | 1250 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
CDA (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online